Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: A cause for hope?

Eurosurveillance

Volumn 22, Issue 47, 2017, Pages

  Hurt, Aeron ^a   Komadina, Naomi ^a   Deng, Yi Mo ^a   Kaye, Matthew ^a   Sullivan, Sheena ^a,b   Subbarao, Kanta ^a   Barr, Ian ^a  

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; AMINO ACID; INFLUENZA VIRUS HEMAGGLUTININ; PROTEIN M2; VIRUS SIALIDASE; ANTIVIRUS AGENT; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; AUSTRALIA; INFLUENZA A (H3N2); INFLUENZA A VIRUS (H3N2); NONHUMAN; PHYLOGENETIC TREE; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS ISOLATION; AMINO ACID SUBSTITUTION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; INFLUENZA; ISOLATION AND PURIFICATION; PHYLOGENY; SEASON; VIROLOGY; VIRUS GENOME;

ADAMANTANE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; AUSTRALIA; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; PHYLOGENY; RNA, VIRAL; SEASONS; SEQUENCE ANALYSIS, DNA;

EID: 85036654117     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2017.22.47.17-00731     Document Type: Article

References (18)

1. Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev. 2004; (3):CD001169.
2. Hayden FG, Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol. 1992;176:119-30. https://doi.org/10.1007/978-3-642-77011-1_8
3. Ziegler T, Hemphill ML, Ziegler ML, Perez-Oronoz G, Klimov AI, Hampson AW, et al. Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis. 1999;180 (4):935-9. https://doi.org/10.1086/314994
4. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005;366 (9492):1175-81. https://doi.org/10.1016/S0140-6736(05)67338-2
5. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006;295 (8):891-4. https://doi.org/10.1001/jama.295.8.joc60020
6. Deng YM, Spirason N, Iannello P, Jelley L, Lau H, Barr IG. A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses. J Clin Virol. 2015;68:43-8. https://doi.org/10.1016/j.jcv.2015.04.019
7. Zhou B, Deng YM, Barnes JR, Sessions O, Chou TW, Wilson M, et al. Multiplex RT-PCR for Simultaneous Surveillance of Influenza A and B Viruses. J Clin Microbiol. 2017 Oct 4. pii: JCM.00957-17. doi: https://doi.org/10.1128/JCM.00957-17.
8. Deng YM, Caldwell N, Barr IG. Rapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing. PLoS One. 2011;6(8):e23400. https://doi.org/10.1371/journal.pone.0023400
9. Zaraket H, Kondo H, Hibino A, Yagami R, Odagiri T, Takemae N, et al. Japanese Influenza Collaborative Study Group. Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms. Front Microbiol. 2016;7:262. https://doi.org/10.3389/fmicb.2016.00262
10. Mast EE, Harmon MW, Gravenstein S, Wu SP, Arden NH, Circo R, et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol. 1991;134 (9):988-97. https://doi.org/10.1093/oxfordjournals.aje.a116184
11. Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB. Amantadine-resistant influenza A in a nursing facility. Arch Intern Med. 1992;152 (2):390-2. https://doi.org/10.1001/archinte.1992.00400140128027
12. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med. 1989;321 (25):1696-702. https://doi.org/10.1056/NEJM198912213212502
13. Houck P, Hemphill M, LaCroix S, Hirsh D, Cox N. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. Arch Intern Med. 1995;155 (5):533-7. https://doi.org/10.1001/archinte.1995.00430050113012
14. Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics. 1987;80 (2):275-82.
15. Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C, Komadina N. The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006. Antiviral Res. 2007;75 (2):173-6. https://doi.org/10.1016/j.antiviral.2007.01.006
16. Barr IG, Deng YM, Iannello P, Hurt AC, Komadina N. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antiviral Res. 2008;80 (2):200-5. https://doi.org/10.1016/j.antiviral.2008.06.008
17. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, et al. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol. 2007;24 (8):1811-20. https://doi.org/10.1093/molbev/msm103
18. Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, et al. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017 Sep 22. pii: S1473-3099(17)30476-0. doi: https://doi.org/10.1016/S1473-3099(17)30476-0. [Epub ahead of print].